Seeing Is Believing
with an average price target of $10.93. This is a potential upside of $8.17 (296.01%) from yesterday's end of day stock price of $2.76.
Vascular Biogenics Ltd's activity chart (see below) currently has 0 price targets and 7 ratings on display.
Analysts average stock forecasts to be materialized ratio is 37.5% with an average time for these price targets to be met of 155.25 days.
Most recent stock forecast was given by MATTHEW BARCUS from CHARDAN CAPITAL on 21-Jul-2022. First documented stock forecast 20-Aug-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$5
2 years 8 months 3 days ago
(21-Jul-2022)
1/1 (100%)
$3.37 (206.75%)
532
Hold
2 years 8 months 3 days ago
(21-Jul-2022)
1/2 (50%)
$9.48 (151.49%)
89
Hold
2 years 8 months 4 days ago
(20-Jul-2022)
0/1 (0%)
$6.9 (168.29%)
Buy
$17
$14.24 (515.94%)
$22
8 years 7 months 9 days ago
(15-Aug-2016)
0/5 (0%)
$12.94 (318.72%)
What is VBLT (Vascular Biogenics Ltd) average time for price targets to be met?
Which analyst has the current highest performing score on VBLT (Vascular Biogenics Ltd) with a proven track record?
Which analyst has the current lower performing score on VBLT (Vascular Biogenics Ltd) with a proven track record?
Which analyst has the most public recommendations on VBLT (Vascular Biogenics Ltd)?
Which analyst is the currently most bullish on VBLT (Vascular Biogenics Ltd)?
Which analyst is the currently most reserved on VBLT (Vascular Biogenics Ltd)?